Evidence map›Paper›PMID 29511462›Full record

ArticleJournal of extracellular vesicles2018

Proteome profiling of extracellular vesicles captured with the affinity peptide Vn96: comparison of Laemmli and TRIzol© protein-extraction methods.

Andrew P Joy, D Craig Ayre, Ian C Chute, Annie-Pier Beauregard, Gabriel Wajnberg, Anirban Ghosh, Stephen M Lewis, Rodney J Ouellette, David A Barnett

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrew P JoyAtlantic Cancer Research Institute, Moncton, Canada.ORCID 0000-0002-5477-1615
D Craig AyreAtlantic Cancer Research Institute, Moncton, Canada.ORCID 0000-0003-0345-4764
Ian C ChuteAtlantic Cancer Research Institute, Moncton, Canada.ORCID 0000-0002-7449-5013
Annie-Pier BeauregardAtlantic Cancer Research Institute, Moncton, Canada.ORCID 0000-0001-7101-7174
Gabriel WajnbergAtlantic Cancer Research Institute, Moncton, Canada.ORCID 0000-0002-4479-4063
Anirban GhoshAtlantic Cancer Research Institute, Moncton, Canada.ORCID 0000-0002-8735-1780
Stephen M LewisAtlantic Cancer Research Institute, Moncton, Canada.ORCID 0000-0001-9537-5822
Rodney J OuelletteAtlantic Cancer Research Institute, Moncton, Canada.ORCID 0000-0002-2281-2769
David A BarnettAtlantic Cancer Research Institute, Moncton, Canada.ORCID 0000-0001-9205-058X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sample amount is often a limiting factor for multi-parametric analyses that encompass at least three areas of '-omics' research: genomics, transcriptomics and proteomics. Limited sample amounts are also an important consideration when these multi-parametric analyses are performed on extracellular vesicles (EVs), as the amount of EVs (and EV cargo) that can be isolated is often very low. It is well understood that a monophasic solution of phenol and guanidine isothiocyanate (i.e. TRIzol©) can simultaneously isolate DNA, RNA and proteins from biological samples; however, it is most commonly used for the extraction of RNA. Validation of this reagent for the isolation of multiple classes of biological molecules from EVs would provide a widely applicable method for performing multi-parametric analyses of EV material. In this report, we describe a comparison of proteins identified from EVs processed with either TRIzol© or the conventional Laemmli buffer protein-extraction reagents. EVs were isolated from 3 mL of cell-culture supernatant derived from MCF-10A, MCF-7 and MDA-MB-231 cells using the Vn96 EV capture technology. For the TRIzol© extraction protocol, proteins were precipitated with acetone from the organic phase and then re-solubilized in a mixture of 8M urea, 0.2% SDS and 1 M Tris-HCl pH 6.8, followed by dilution in 5× loading buffer prior to fractionation with 1D SDS-PAGE. NanoLC-MS/MS of the trypsin-digested proteins was used to generate proteomic profiles from EV protein samples extracted with each method. Of the identified proteins, 57.7%, 69.2% and 57.0% were common to both extraction methods for EVs from MCF-10A, MCF-7 and MDA-MB-231, respectively. Our results suggest that TRIzol© extraction of proteins from EVs has significant equivalence to the traditional Laemmli method. The advantage of using TRIzol

Indexed as

cell-conditioned mediaexosomesextracellular vesicleMCF-10AMCF-7MDA-MB-231Vn96

Identifiers

PMID29511462
PMCPMC5827780

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.